DOCSLIB.ORG

DNA Microarray Technology in Dermatology Manfred Kunz, MD

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
DNA Microarray Technology in Dermatology Manfred Kunz, MD DNA Microarray Technology in Dermatology Manfred Kunz, MD In recent years, DNA microarray technology has been used for the analysis of gene expression patterns in a variety of skin diseases, including malignant melanoma, psoriasis, lupus erythematosus, and systemic sclerosis. Many of the studies described herein con- firmed earlier results on individual genes or functional groups of genes. However, a plethora of new candidate genes, gene patterns, and regulatory pathways have been identified. Major progresses were reached by the identification of a prognostic gene pattern in malignant melanoma, an immune signaling cluster in psoriasis, and a so-called interferon signature in systemic lupus erythematosus. In future, interference with genes or regulatory pathways with the use of different RNA interference technologies or targeted therapy may not only underscore the functional significance of microarray data but also may open interesting therapeutic perspectives. Large-scale gene expression analyses may also help to design more individualized treatment approaches of cutaneous diseases. Semin Cutan Med Surg 27:16-24 © 2008 Elsevier Inc. All rights reserved. KEYWORDS genomics, melanoma/skin tumors, inflammatory skin diseases, autoimmune diseases ene microarray technology started in the early couldnineties be used to measure mRNA molecules within a wide G of the last century. It was demonstrated that linearpeptides range of 3 to 4 orders of magnitude, with a sensitiv- may be synthesized on small silicon chips by photolitho-ity of a few molecules per cell. Indeed, later studies con- graphic synthesis.1,2 This technique was then applied to firmedshort that the detection lower limit of current microarray DNA fragments, generating so-called DNA microarrays technology(un- appears to be around ten copies of mRNA per less otherwise stated, in the present review the termcell. microar-5,6 As a consequence, low abundance genes such as rays refers to DNA microarrays). By use of these microarrays,transcription factors may sometimes be lost, or at least not the amount mRNA molecules in a given biologicalreliably sample be detected by DNA microarrays. When compar- may be quantified with high accuracy via complementarying results from different technical platforms, consistency binding of mRNAs to the DNA probes fixed on theof datamicroar- for differentially expressed genes was disappoint- ray.3 The development of oligonucleotide DNA microarraysing, as reported a few years7 This ago.was in attribut-part was paralleled by that of cDNA microarrays, usingable 600 to tothe fact that in these analyses genes,low abundance 2000 bases cDNA molecules as 4 Recentprobes. progress in which may often not accurately be detected, were not array technology demonstrated equal sensitivity for DNAfiltered mi- out. Moreover, sufficient probe sequence informa- croarrays carrying probes of 60 to 80 bases in tionlength. was Atnot available of different platforms, and different present, the latest oligonucleotide and cDNA microarraysprobe sequences for individual genes could thus not be carry probes for expression analysis of all currentlytaken known into consideration. As reported recently by the Mi- genes (more than 35,000). In parallel to these whole-genomecroarray Quality Control Project, high intra- and interplat- chips, several companies offer more specific microarraysform forconsistency may be reached due to an optimization mRNA expression analysis of specific gene subsets. of probe sequences and appropriate 8 filtering. 3 In the mentioned report by Lockhart and itcoworkers,High specificity of DNA microarrays allows detection of was demonstrated that oligonucleotide DNA microarraysthe exchange of even one single base when using appro- priate short oligonucleotides (so called single-base resolu- tion). As a consequence, oligonucleotide DNA microarrays Department of Dermatology and Venereology, University of Rostock, Ros- also may be used for DNA sequencing.9 Specific DNA mi- tock, Germany. Address correspondence to Manfred Kunz, MD, Department of Derma- croarrays were used to detect mutations in certain tumor- 10,11 tology and Venereology, Augustenstr. 80-84, 18055 Rostock, Ger- associated genes such as BRCA1 and p53, respectively. many. E-mail: [email protected] A further application of DNA microarray technology, cur- 16 1085-5629/08/$-see front matter © 2008 Elsevier Inc. All rights reserved. doi:10.1016/j.sder.2007.12.004 DNA microarray technology in dermatology 17 Table 1 Current Key Genomics and Proteomics Technologies Number of Sensitivity Technology Targets Targets Sensitivity* Threshold† Specificity References Oligonucleotide and mRNAs >35,000 High (>90%) Low (ϳ10 mRNA High (70-90%)‡ 5,6,12 cDNA microarrays (whole genome) copies per cell) Oligonucleotide SNPs ϳ 1,000,000 High (>95%) NA High (>95%) 14-16 microarrays Protein and antibody Proteins 1,000-5,000 High (>90%) Low ϳ 20 pg Low to intermediate 18,19 microarrays (20-50%) 2D gel electrophoresis Proteins 100,000-500,000 Low (<10%) Low ϳ 1 ng High (>75%) 18,19 combined with mass spectrometry NA, not applicable. *Sensitivity refers to the number of mRNAs, SNPs, or proteins detected in a complex background relative to the total number of mRNAs, SNPs, or proteins that might theoretically be detected by this particular technology. †Sensitivity threshold refers to the lower limit of sensitivity for a specific mRNA or protein. ‡Estimated value based on analyses of a limited number of genes. Systematic studies on probe specificity for all genes are lacking. rently attracting widespread attention, is the identification parts per million). However, even with high-resolution pro- of single nucleotide polymorphisms (SNPs).12-17 SNPs are tein separation of 2D gels, the number of proteins that may be homozygous or heterozygous nucleotide variations in the identified is generally less than 10,000. A summary of tech- human genome, with an estimated incidence of about one nological issues of key genome and proteome technologies is SNP every 300 to 1000 base pairs (bps). SNPs may con- given in Table 1. tribute to tumor development and progression and may A major challenge in particular for DNA microarray anal- predispose one to a variety of different diseases, such as yses is data processing and biostatistics. Before microarray diabetes, high blood pressure, and arthritis.17 At present, data may be subjected to detailed analysis, preprocessing of the total number of SNPs in public databases exceeds 9 raw data must be performed,20,21 including image analysis, million. Current DNA microarray technology may detect summarization and normalization.22 In particular, each mi- up to 1 million human SNPs.16,17 Oligonucleotide mi- croarray must be normalized to all other microarrays of an croarrays used for SNP detection differ from those for experiment so that all microarrays are comparable.23 Statisti- mRNA expression analysis. In principle, in SNP arrays cal analysis of microarray data includes so-called supervised four oligonucleotide probes are designed to interrogate a and unsupervised methods. Supervised methods generally single position. One probe binds with perfect complemen- are applied when a class label for each sample is known, for tarity to the reference sequence in the sample DNA. The instance, each sample may unambiguously be attributed to a other 3 differ from the first at the interrogation position by defined clinical or histopathological entity. Supervised clus- substitution of 1 of the 3 other bases, which leads to non- tering methods may then identify differentially expressed perfect binding.12 The complementary probe variant re- genes or predict the class label of new unknown samples. The sults in significantly enhanced signal intensity compared corresponding computational techniques are support vector with the others, thus allowing exact identification of a machines, neural networks, or partitioning around medoids particular SNP. (ie. PAM) approaches.24-26 These approaches normally use a Because differential gene expression does not necessarily majority of samples as a training set, on which a so-called translate into differential protein expression, technological classifier is build. This classifier can then be used to predict platforms for large-scale protein (proteome) analyses have the classification of a test sample. been developed in recent years.18 In so-called forward-phase If there are no clearly defined groups or subgroups with protein microarrays, predefined antibodies are immobilized class labels, unsupervised methods (clustering) may be on a glass slide to interrogate a given protein sample (eg, a applied. A series of different methods are in use for cluster cellular lysate).18,19 In reverse-phase microarrays, a complex analysis, like k-means clustering or hierarchical clustering, protein mixture is immobilized on a glass slide, which is then as described by Eisen and coworkers.27 In the latter case, probed with specific antibodies.18,19 The detection lower hierarchical cluster trees are generated that juxtapose limit of protein concentrations when one is using protein genes based on the similarity of expression profiles. For microarrays may reach a 10-cell equivalent. However, the better optical presentation, expression levels of genes are most commonly used technology for proteome analysis is a represented by color squares. Clustering may also be per- combination of 2D gel electrophoresis for protein separation formed by so-called self-organizing maps (SOMs),28 which and mass spectrometry for protein identification.18
Load more

Recommended publications
  • Metallothionein Monoclonal Antibody, Clone N11-G
    Metallothionein monoclonal antibody, clone N11-G Catalog # : MAB9787 規格 : [ 50 uL ] List All Specification Application Image Product Rabbit monoclonal antibody raised against synthetic peptide of MT1A, Western Blot (Recombinant protein) Description: MT1B, MT1E, MT1F, MT1G, MT1H, MT1IP, MT1L, MT1M, MT2A. Immunogen: A synthetic peptide corresponding to N-terminus of human MT1A, MT1B, MT1E, MT1F, MT1G, MT1H, MT1IP, MT1L, MT1M, MT2A. Host: Rabbit enlarge Reactivity: Human, Mouse Immunoprecipitation Form: Liquid Enzyme-linked Immunoabsorbent Assay Recommend Western Blot (1:1000) Usage: ELISA (1:5000-1:10000) The optimal working dilution should be determined by the end user. Storage Buffer: In 20 mM Tris-HCl, pH 8.0 (10 mg/mL BSA, 0.05% sodium azide) Storage Store at -20°C. Instruction: Note: This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only. Datasheet: Download Applications Western Blot (Recombinant protein) Western blot analysis of recombinant Metallothionein protein with Metallothionein monoclonal antibody, clone N11-G (Cat # MAB9787). Lane 1: 1 ug. Lane 2: 3 ug. Lane 3: 5 ug. Immunoprecipitation Enzyme-linked Immunoabsorbent Assay ASSP5 MT1A MT1B MT1E MT1F MT1G MT1H MT1M MT1L MT1IP Page 1 of 5 2021/6/2 Gene Information Entrez GeneID: 4489 Protein P04731 (Gene ID : 4489);P07438 (Gene ID : 4490);P04732 (Gene ID : Accession#: 4493);P04733 (Gene ID : 4494);P13640 (Gene ID : 4495);P80294 (Gene ID : 4496);P80295 (Gene ID : 4496);Q8N339 (Gene ID : 4499);Q86YX0 (Gene ID : 4490);Q86YX5
    [Show full text]
  • Endostatin: a Novel Inhibitor of Androgen Receptor Function in Prostate Cancer
    Endostatin: A novel inhibitor of androgen receptor function in prostate cancer Joo Hyoung Leea, Tatyana Isayevaa, Matthew R. Larsonb, Anandi Sawanta, Ha-Ram Chaa, Diptiman Chandaa, Igor N. Chesnokovc, and Selvarangan Ponnazhagana,1 Departments of aPathology and cBiochemistry and Molecular Genetics, University of Alabama, Birmingham, AL 35294; and bDepartment of Biological Chemistry, University of Michigan Medical Center, Ann Arbor, MI 48109 Edited* by Louise T. Chow, University of Alabama at Birmingham, Birmingham, AL, and approved December 29, 2014 (received for review September 12, 2014) Acquired resistance to androgen receptor (AR)-targeted therapies a C-terminal LBD. Like other nuclear receptors (NRs), AR is a compels the development of novel treatment strategies for castra- transcription factor regulating target-gene expression in a ligand- tion-resistant prostate cancer (CRPC). Here, we report a profound dependent manner (2, 16). Cognate ligand binding induces effect of endostatin on prostate cancer cells by efficient intracellular conformational changes predominantly in helix 12 of AR trafficking, direct interaction with AR, reduction of nuclear AR level, LBD, which enhances transcriptional activity by forming a ligand- and down-regulation of AR-target gene transcription. Structural dependent AF-2 binding interface for coactivators (17). Wilson modeling followed by functional analyses further revealed that and colleagues demonstrated that the interdomain interaction phenylalanine-rich α1-helix in endostatin—which shares struc- between AF-1 in NTD and AF-2 in LBD (N/C interaction) leads tural similarity with noncanonical nuclear receptor box in AR— to AR stabilization and slower ligand dissociation (18, 19). antagonizes AR transcriptional activity by occupying the activation Functional activity of AR largely depends on AF-2 that function (AF)-2 binding interface for coactivators and N-terminal accommodates the binding of various AR coactivators by rec- AR AF-1.
    [Show full text]
  • CD56+ T-Cells in Relation to Cytomegalovirus in Healthy Subjects and Kidney Transplant Patients
    CD56+ T-cells in Relation to Cytomegalovirus in Healthy Subjects and Kidney Transplant Patients Institute of Infection and Global Health Department of Clinical Infection, Microbiology and Immunology Thesis submitted in accordance with the requirements of the University of Liverpool for the degree of Doctor in Philosophy by Mazen Mohammed Almehmadi December 2014 - 1 - Abstract Human T cells expressing CD56 are capable of tumour cell lysis following activation with interleukin-2 but their role in viral immunity has been less well studied. The work described in this thesis aimed to investigate CD56+ T-cells in relation to cytomegalovirus infection in healthy subjects and kidney transplant patients (KTPs). Proportions of CD56+ T cells were found to be highly significantly increased in healthy cytomegalovirus-seropositive (CMV+) compared to cytomegalovirus-seronegative (CMV-) subjects (8.38% ± 0.33 versus 3.29%± 0.33; P < 0.0001). In donor CMV-/recipient CMV- (D-/R-)- KTPs levels of CD56+ T cells were 1.9% ±0.35 versus 5.42% ±1.01 in D+/R- patients and 5.11% ±0.69 in R+ patients (P 0.0247 and < 0.0001 respectively). CD56+ T cells in both healthy CMV+ subjects and KTPs expressed markers of effector memory- RA T-cells (TEMRA) while in healthy CMV- subjects and D-/R- KTPs the phenotype was predominantly that of naïve T-cells. Other surface markers, CD8, CD4, CD58, CD57, CD94 and NKG2C were expressed by a significantly higher proportion of CD56+ T-cells in healthy CMV+ than CMV- subjects. Functional studies showed levels of pro-inflammatory cytokines IFN-γ and TNF-α, as well as granzyme B and CD107a were significantly higher in CD56+ T-cells from CMV+ than CMV- subjects following stimulation with CMV antigens.
    [Show full text]
  • To DNA Microarrays
    Glass slides to DNA microarrays by Samuel D. Conzone* and Carlo G. Pantano† A tremendous interest in deoxyribonucleic acid Most individuals, outside of academic circles focused (DNA) characterization tools was spurred by the on genomics, became aware of the potential mapping and sequencing of the human genome. commercial, technical, and social importance of the New tools were needed, beginning in the early 1990s, human genome project during the late 1990s. The human genome project was formally initiated in to cope with the unprecedented amount of genomic 19901 and was expected to last 15 years. It had the information that was being discovered. Such needs major goals of identifying all the genes in human led to the development of DNA microarrays; tiny DNA, determining the sequences of those genes, and gene-based sensors traditionally prepared on coated storing the information in public databases. glass microscope slides. The following review is However, the project moved quickly from the onset intended to provide historical insight into the advent and, by 1998, the Department of Energy (DOE) and of the DNA microarray, followed by a description of the National Institutes of Health (NIH) predicted the technology from both the application and that the human genome project would be completed by 2003. fabrication points of view. Finally, the unmet challenges and needs associated with DNA The big buzz about biotech microarrays will be described to define areas of The tremendous success in rapidly mapping and sequencing potential future developments for the materials the human genome (a working draft sequence of the human researcher. genome was completed in 2000), has led many commentators to predict that similar achievements would follow on the applications side, giving rise to unprecedented discoveries related to human health2,3.
    [Show full text]
  • Investigation of Structural Properties of Methylated Human Promoter Regions in Terms of Dna Helical Rise
    INVESTIGATION OF STRUCTURAL PROPERTIES OF METHYLATED HUMAN PROMOTER REGIONS IN TERMS OF DNA HELICAL RISE A THESIS SUBMITTED TO THE GRADUATE SCHOOL OF INFORMATICS OF MIDDLE EAST TECHNICAL UNIVERSITY BY BURCU YALDIZ IN PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR THE DEGREE OF MASTER OF SCIENCE IN BIOINFORMATICS AUGUST 2014 INVESTIGATION OF STRUCTURAL PROPERTIES OF METHYLATED HUMAN PROMOTER REGIONS IN TERMS OF DNA HELICAL RISE submitted by Burcu YALDIZ in partial fulfillment of the requirements for the degree of Master of Science, Bioinformatics Program, Middle East Technical University by, Prof. Dr. Nazife Baykal _____________________ Director, Informatics Institute Assist. Prof. Dr. Yeşim Aydın Son _____________________ Head of Department, Health Informatics, METU Assist. Prof. Dr. Yeşim Aydın Son Supervisor, Health Informatics, METU _____________________ Examining Committee Members: Assoc. Prof. Dr. Tolga Can _____________________ METU, CENG Assist. Prof. Dr. Yeşim Aydın Son _____________________ METU, Health Informatics Assist. Prof. Dr. Aybar Can Acar _____________________ METU, Health Informatics Assist. Prof. Dr. Özlen Konu _____________________ Bilkent University, Molecular Biology and Genetics Assoc. Prof. Dr. Çağdaş D. Son _____________________ METU, Biology Date: 27.08.2014 I hereby declare that all information in this document has been obtained and presented in accordance with academic rules and ethical conduct. I also declare that, as required by these rules and conduct, I have fully cited and referenced all material and results that are not original to this work. Name, Last name : Burcu Yaldız Signature : iii ABSTRACT INVESTIGATION OF STRUCTURAL PROPERTIES OF METHYLATED HUMAN PROMOTER REGIONS IN TERMS OF DNA HELICAL RISE Yaldız, Burcu M.Sc. Bioinformatics Program Advisor: Assist. Prof. Dr. Yeşim Aydın Son August 2014, 60 pages The infamous double helix structure of DNA was assumed to be a rigid, uniformly observed structure throughout the genomic DNA.
    [Show full text]
  • Supplement 1 Microarray Studies
    EASE Categories Significantly Enriched in vs MG vs vs MGC4-2 Pt1-C vs C4-2 Pt1-C UP-Regulated Genes MG System Gene Category EASE Global MGRWV Pt1-N RWV Pt1-N Score FDR GO Molecular Extracellular matrix cellular construction 0.0008 0 110 genes up- Function Interpro EGF-like domain 0.0009 0 regulated GO Molecular Oxidoreductase activity\ acting on single dono 0.0015 0 Function GO Molecular Calcium ion binding 0.0018 0 Function Interpro Laminin-G domain 0.0025 0 GO Biological Process Cell Adhesion 0.0045 0 Interpro Collagen Triple helix repeat 0.0047 0 KEGG pathway Complement and coagulation cascades 0.0053 0 KEGG pathway Immune System – Homo sapiens 0.0053 0 Interpro Fibrillar collagen C-terminal domain 0.0062 0 Interpro Calcium-binding EGF-like domain 0.0077 0 GO Molecular Cell adhesion molecule activity 0.0105 0 Function EASE Categories Significantly Enriched in Down-Regulated Genes System Gene Category EASE Global Score FDR GO Biological Process Copper ion homeostasis 2.5E-09 0 Interpro Metallothionein 6.1E-08 0 Interpro Vertebrate metallothionein, Family 1 6.1E-08 0 GO Biological Process Transition metal ion homeostasis 8.5E-08 0 GO Biological Process Heavy metal sensitivity/resistance 1.9E-07 0 GO Biological Process Di-, tri-valent inorganic cation homeostasis 6.3E-07 0 GO Biological Process Metal ion homeostasis 6.3E-07 0 GO Biological Process Cation homeostasis 2.1E-06 0 GO Biological Process Cell ion homeostasis 2.1E-06 0 GO Biological Process Ion homeostasis 2.1E-06 0 GO Molecular Helicase activity 2.3E-06 0 Function GO Biological
    [Show full text]
  • Expression Profiling of KLF4
    Expression Profiling of KLF4 AJCR0000006 Supplemental Data Figure S1. Snapshot of enriched gene sets identified by GSEA in Klf4-null MEFs. Figure S2. Snapshot of enriched gene sets identified by GSEA in wild type MEFs. 98 Am J Cancer Res 2011;1(1):85-97 Table S1: Functional Annotation Clustering of Genes Up-Regulated in Klf4 -Null MEFs ILLUMINA_ID Gene Symbol Gene Name (Description) P -value Fold-Change Cell Cycle 8.00E-03 ILMN_1217331 Mcm6 MINICHROMOSOME MAINTENANCE DEFICIENT 6 40.36 ILMN_2723931 E2f6 E2F TRANSCRIPTION FACTOR 6 26.8 ILMN_2724570 Mapk12 MITOGEN-ACTIVATED PROTEIN KINASE 12 22.19 ILMN_1218470 Cdk2 CYCLIN-DEPENDENT KINASE 2 9.32 ILMN_1234909 Tipin TIMELESS INTERACTING PROTEIN 5.3 ILMN_1212692 Mapk13 SAPK/ERK/KINASE 4 4.96 ILMN_2666690 Cul7 CULLIN 7 2.23 ILMN_2681776 Mapk6 MITOGEN ACTIVATED PROTEIN KINASE 4 2.11 ILMN_2652909 Ddit3 DNA-DAMAGE INDUCIBLE TRANSCRIPT 3 2.07 ILMN_2742152 Gadd45a GROWTH ARREST AND DNA-DAMAGE-INDUCIBLE 45 ALPHA 1.92 ILMN_1212787 Pttg1 PITUITARY TUMOR-TRANSFORMING 1 1.8 ILMN_1216721 Cdk5 CYCLIN-DEPENDENT KINASE 5 1.78 ILMN_1227009 Gas2l1 GROWTH ARREST-SPECIFIC 2 LIKE 1 1.74 ILMN_2663009 Rassf5 RAS ASSOCIATION (RALGDS/AF-6) DOMAIN FAMILY 5 1.64 ILMN_1220454 Anapc13 ANAPHASE PROMOTING COMPLEX SUBUNIT 13 1.61 ILMN_1216213 Incenp INNER CENTROMERE PROTEIN 1.56 ILMN_1256301 Rcc2 REGULATOR OF CHROMOSOME CONDENSATION 2 1.53 Extracellular Matrix 5.80E-06 ILMN_2735184 Col18a1 PROCOLLAGEN, TYPE XVIII, ALPHA 1 51.5 ILMN_1223997 Crtap CARTILAGE ASSOCIATED PROTEIN 32.74 ILMN_2753809 Mmp3 MATRIX METALLOPEPTIDASE
    [Show full text]
  • Architecture of Thermal Adaptation in an Exiguobacterium Sibiricum Strain
    BMC Genomics BioMed Central Research article Open Access Architecture of thermal adaptation in an Exiguobacterium sibiricum strain isolated from 3 million year old permafrost: A genome and transcriptome approach Debora F Rodrigues*1, Natalia Ivanova2, Zhili He3, Marianne Huebner4, Jizhong Zhou3 and James M Tiedje1 Address: 1Michigan State University, NASA Astrobiology Institute and Center for Microbial Ecology, East Lansing, MI 48824, USA, 2DOE Joint Genome Institute, Walnut Creek, CA 94598-1604, USA, 3Institute for Environmental Genomics, Department of Botany and Microbiology, University of Oklahoma, Norman, OK, USA and 4Michigan State University, Department of Statistics and Probability, East Lansing, MI, USA Email: Debora F Rodrigues* - [email protected]; Natalia Ivanova - [email protected]; Zhili He - [email protected]; Marianne Huebner - [email protected]; Jizhong Zhou - [email protected]; James M Tiedje - [email protected] * Corresponding author Published: 18 November 2008 Received: 23 May 2008 Accepted: 18 November 2008 BMC Genomics 2008, 9:547 doi:10.1186/1471-2164-9-547 This article is available from: http://www.biomedcentral.com/1471-2164/9/547 © 2008 Rodrigues et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Abstract Background: Many microorganisms have a wide temperature growth range and versatility to tolerate large thermal fluctuations in diverse environments, however not many have been fully explored over their entire growth temperature range through a holistic view of its physiology, genome, and transcriptome.
    [Show full text]
  • Annals of Medical and Clinical Oncology Chen C, Et Al
    Annals of Medical and Clinical Oncology Chen C, et al. Ann med clin Oncol 3: 125. Short Commentary DOI: 10.29011/AMCO-125.000125 Commentary Referring to Pericyte FAK Negatively Regulates Gas6/ Axl Signalling To Suppress Tumour Angiogenesis and Tumour Growth Chen Chen, Hongyan Wang, Binfeng Wu and Jinghua Chen* Key Laboratory of Carbohydrate Chemistry and Biotechnology, Ministry of Education, School of Pharmaceutical Sciences, Jiangnan University, Wuxi 214122, PR China *Corresponding author: Jinghua Chen, Key Laboratory of Carbohydrate Chemistry and Biotechnology, Ministry of Education, School of Pharmaceutical Sciences, Jiangnan University, Wuxi 214122, PR China Citation: Chen C, Wang H, Wu B, Chen J (2020) Commentary Referring to Pericyte FAK Negatively Regulates Gas6/Axl Signalling To Suppress Tumour Angiogenesis and Tumour Growth. Ann med clin Oncol 3: 125. DOI: 10.29011/AMCO-125.000125 Received Date: 07 December, 2020; Accepted Date: 20 December, 2020; Published Date: 28 December, 2020 The published research article utilized multiple mouse Interestingly, knockout of FAK was specific to pericytes other models including melanoma, lung carcinoma and pancreatic B-cell than endothelial cells, mice models demonstrated that loss of insulinoma. Two hallmarks of cancer [1] such as angiogenesis and FAK from pericytes significantly promoted ɑ-SMA expression tumour growth had been evaluated. Two major molecules FAK (common metastatic biomarker) and NG-2 (typical angiogenesis (focal adhesion kinase 1) and Axl undertook the innovative roles related biomarker) in three cancer cells model. It suggested that of this elegant paper. They both belong to protein Tyrosine Kinase FAK may function as the tumour suppressive gene. However, (TK) family [2].
    [Show full text]
  • Cysteine-Rich 61 (Cyr61): a Biomarker Reflecting Disease Activity In
    Fan et al. Arthritis Research & Therapy (2019) 21:123 https://doi.org/10.1186/s13075-019-1906-y RESEARCHARTICLE Open Access Cysteine-rich 61 (Cyr61): a biomarker reflecting disease activity in rheumatoid arthritis Yong Fan†, Xinlei Yang†, Juan Zhao, Xiaoying Sun, Wenhui Xie, Yanrong Huang, Guangtao Li, Yanjie Hao and Zhuoli Zhang* Abstract Background: Numerous preclinical studies have revealed a critical role of cysteine-rich 61 (Cyr61) in the pathogenesis of rheumatoid arthritis (RA). But there is little literature discussing the clinical value of circulation Cyr61 in RA patients. The aim of our study is to investigate the serum Cyr61 level and its association with disease activity in RA patients. Methods: A training cohort was derived from consecutive RA patients who visited our clinic from Jun 2014 to Nov 2018. Serum samples were obtained at the enrollment time. To further confirm discovery, an independent validation cohort was set up based on a registered clinical trial. Paired serum samples of active RA patients were respectively collected at baseline and 12 weeks after uniformed treatment. Serum Cyr61 concentration was detected by enzyme-linked immunosorbent assay. The comparison of Cyr61 between RA patients and controls, the correlation between Cyr61 levels with disease activity, and the change of Cyr61 after treatment were analyzed by appropriate statistical analyses. Results: A total of 177 definite RA patients and 50 age- and gender-matched healthy controls were enrolled in the training cohort. Significantly elevated serum Cyr61 concentration was found in RA patients, demonstrating excellent diagnostic ability to discriminate RA from healthy controls (area under the curve (AUC) = 0.98, P < 0.001).
    [Show full text]
  • The Procollagen N-Proteinases ADAMTS2, 3 and 14 in Pathophysiology
    Review The procollagen N-proteinases ADAMTS2, 3 and 14 in pathophysiology Mourad Bekhouche and Alain Colige Laboratory of Connective Tissues Biology, GIGA-R, University of Liège, B-4000 Sart Tilman, Belgium Correspondence to Alain Colige: Laboratory of Connective Tissues Biology, University of Liège, GIGA-Research, Tour de Pathologie B23/3, Avenue de l'Hôpital, 3, B-4000 Sart Tilman, Belgium. [email protected] http://dx.doi.org/10.1016/j.matbio.2015.04.001 Edited by W.C. Parks and S. Apte Abstract Collagen fibers are the main components of most of the extracellular matrices where they provide a structural support to cells, tissues and organs. Fibril-forming procollagens are synthetized as individual chains that associate to form homo- or hetero-trimers. They are characterized by the presence of a central triple helical domain flanked by amino and carboxy propeptides. Although there are some exceptions, these two propeptides have to be proteolytically removed to allow the almost spontaneous assembly of the trimers into collagen fibrils and fibers. While the carboxy-propeptide is mainly cleaved by proteinases from the tolloid family, the amino-propeptide is usually processed by procollagen N-proteinases: ADAMTS2, 3 and 14. This review summarizes the current knowledge concerning this subfamily of ADAMTS enzymes and discusses their potential involvement in physiopathological processes that are not directly linked to fibrillar procollagen processing. © 2015 Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). Introduction determine the cause of dermatosparaxis, a rare genetic disease that appeared in Belgian cattle herds during an Fibrillar collagens are the most abundant proteins inbreeding program [2,3].
    [Show full text]
  • Salt-Inducible Kinases Dictate Parathyroid Hormone Receptor Action in Bone Development and Remodeling
    Salt-inducible kinases dictate parathyroid hormone receptor action in bone development and remodeling Shigeki Nishimori, … , Henry M. Kronenberg, Marc N. Wein J Clin Invest. 2019. https://doi.org/10.1172/JCI130126. Research In-Press Preview Bone Biology Endocrinology The parathyroid hormone receptor (PTH1R) mediates the biologic actions of parathyroid hormone (PTH) and parathyroid hormone related protein (PTHrP). Here, we showed that salt inducible kinases (SIKs) are key kinases that control the skeletal actions downstream of PTH1R and that this GPCR, when activated, inhibited cellular SIK activity. Sik gene deletion led to phenotypic changes that were remarkably similar to models of increased PTH1R signaling. In growth plate chondrocytes, PTHrP inhibited SIK3 and ablation of this kinase in proliferating chondrocytes rescued perinatal lethality of PTHrP-null mice. Combined deletion of Sik2/Sik3 in osteoblasts and osteocytes led to a dramatic increase in bone mass that closely resembled the skeletal and molecular phenotypes observed when these bone cells express a constitutively active PTH1R that causes Jansen’s metaphyseal chondrodysplasia. Finally, genetic evidence demonstrated that class IIa HDACs were key PTH1R-regulated SIK substrates in both chondrocytes and osteocytes. Taken together, our findings established that SIK inhibition is central to PTH1R action in bone development and remodeling. Furthermore, this work highlighted the key role of cAMP-regulated salt inducible kinases downstream of GPCR action. Find the latest version: https://jci.me/130126/pdf 1 Salt-inducible kinases dictate parathyroid hormone receptor action in bone development 2 and remodeling 3 4 Shigeki Nishimori1,2, Maureen J. O’Meara1, Christian Castro1, Hiroshi Noda1,3, Murat Cetinbas4, 5 Janaina da Silva Martins1, Ugur Ayturk5, Daniel J.
    [Show full text]